adlyxin
Pharmaranks rates Adlyxin 3.5/5 for recall safety — an independent score from its FDA recall history and its manufacturer's record. Adlyxin (Lixisenatide) is a medication used to treat Type 2 Diabetes Mellitus.
Lixisenatide · by Sanofi Aventis US
Based on 1 source · Recall-safety score from FDA recall history — this product's own recalls and its manufacturer's record. Not an efficacy or quality rating. methodology →
Key facts
- Active ingredient
- Lixisenatide
- Form
- Solution
- Strength
- Lixisenatide 0.15MG/3ML (0.05MG/ML) · Lixisenatide 0.3MG/3ML (0.1MG/ML)
- Type
- Prescription (Rx)
- Brand or generic
- Brand-name
- May treat
- type 2 diabetes mellitus
- Manufacturer
- Sanofi Aventis US
- FDA application
- BLA208471
May treat (source: NIH RxClass)
Dosage forms
Solution
The forms currently marketed in the U.S., per the FDA National Drug Code Directory.
Ways to save
Ask for the generic
Same active ingredient, far cheaper. Is there a generic? →
Request a 90-day supply
Bulk fills usually lower the per-dose price vs monthly refills.
Use copay cards
Manufacturer copay cards & patient-assistance programs — especially for brand drugs.
Compare alternatives
A same-class option may cost less. See alternatives →
Frequently asked questions
- What does Adlyxin treat?
- Adlyxin (Lixisenatide) may be used to treat type 2 diabetes mellitus, based on NIH RxClass drug-classification data (conditions a drug may treat — not a verbatim copy of the FDA-approved label). This is general reference, not medical advice.
- How is Adlyxin rated?
- pharmaranks gives Adlyxin a composite score of 3.5 out of 5, currently based on 1 weighted source (FDA regulatory recall-safety data weighted highest). See our methodology at /how-we-rate.
- Is there a coupon or discount for Adlyxin?
- pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Adlyxin. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.
- Who makes Adlyxin?
- Adlyxin is marketed by Sanofi Aventis US. You can see Sanofi Aventis US's full profile, rating, and other products on pharmaranks.
- Is Adlyxin a brand-name or generic drug?
- Adlyxin is a brand-name product with the active ingredient Lixisenatide.
- Is Adlyxin available over the counter?
- No. Adlyxin is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.
- What forms does Adlyxin come in?
- Adlyxin is currently marketed as solution, per the FDA's National Drug Code Directory.
- Is Adlyxin FDA-registered?
- Adlyxin is on record with the U.S. FDA under application number BLA208471. You can verify this on its official FDA label.
- Has Adlyxin been recalled by the FDA?
- Adlyxin has no FDA recalls recorded under its own application in the openFDA enforcement database. Its recall-safety score reflects its manufacturer's overall recall record. This is general reference, not medical advice — check the FDA recall database for the latest alerts.
- Is Adlyxin safe?
- There's no single safe-or-not verdict. pharmaranks gives Adlyxin a recall-safety score of 70/100, based on its FDA recall history (no recalls under its own FDA application) — not an efficacy or side-effect rating. Review its FDA-label side effects and warnings before use, and always consult a licensed professional.
Information is sourced from public FDA regulatory data. Provided for general reference only — not medical advice. Always consult a licensed professional and the current prescribing information.
What people report to the FDA about LIXISENATIDE
The FDA Adverse Event Reporting System (FAERS) collects reports from patients and clinicians. It holds 334 reports naming LIXISENATIDE — the active ingredient in Adlyxin, and the FDA flagged 91% of those reports as serious. The effects reported most often — leaving out reports about overdose, misuse or the condition being treated, which dominate the raw list for common medicines:
- blood glucose increased40 reports
- nausea32 reports
- hypoglycaemia28 reports
- diarrhoea25 reports
- vomiting24 reports
- malaise23 reports
- weight decreased19 reports
- diabetic ketoacidosis18 reports
Read these as a signal, not a rate. A report does not mean LIXISENATIDE caused the effect — anyone can file one, and many describe people taking several medicines for several conditions. Crucially there is no denominator: FAERS does not record how many people took the drug, so these counts cannot be turned into “X% of patients” — a bigger number often just means a more widely used or more talked-about drug. Duplicates exist, and publicity drives reporting. For what is actually established, read the FDA label.
Source: openFDA drug/event (FAERS), retrieved September 25, 2026.
Reviews
No reviews yet. Be the first to write one.
People also viewed
brynovin
Sitagliptin Hydrochloride
invokana
Canagliflozin
merilog
Insulin Aspart-Szjj
merilog solostar
Insulin Aspart-Szjj
rezvoglar
Insulin Glargine-Aglr
tradjenta
Linagliptin
Compare Adlyxin head-to-head
Browse medications A–Z
Research products from A to Z, compare independent ratings, and find alternatives.
adlyxin
70/100